High
4.400
Open
4.000
VWAP
3.88
Vol
107.64K
Mkt Cap
225.44M
Low
3.255
Amount
417.52K
EV/EBITDA(TTM)
--
Total Shares
51.94M
EV
227.02M
EV/OCF(TTM)
--
P/S(TTM)
10.27
Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
Show More
Valuation Metrics
The current forward P/E ratio for Wellgistics Health Inc (WGRX.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Wellgistics Health Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financials
Annual
Quarterly
FY2024Q4
12.41M
Total Revenue
FY2024Q4
YoY :
+253.18%
-3.75M
Operating Profit
FY2024Q4
YoY :
+302.52%
-4.33M
Net Income after Tax
FY2024Q4
YoY :
+550.00%
-0.13
EPS - Diluted
FY2024Q4
-2.77M
Free Cash Flow
FY2024Q4
4.85
Gross Profit Margin - %
FY2024Q4
-8.84
FCF Margin - %
FY2024Q4
-34.90
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
WGRX News & Events
Events Timeline
2025-04-24 (ET)
2025-04-24
07:43:55
Wellgistics Health appoints Mark DiSiena as CFO
2025-04-24
07:43:21
Wellgistics Health appoints Mark DiSiena as CEO
2025-04-15 (ET)
2025-04-15
07:41:55
Wellgistics Health CEO converts $1.5M of debt to equity
Sign Up For More Events
Sign Up For More Events
News
5.0
03-04NewsfilterWellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning's Departure
7.5
02-26Business InsiderWellgistics Health subsidiary enters agreement with Tollo Health
Sign Up For More News
People Also Watch
LAAC
Lithium Americas (Argentina) Corp
2.740
USD
0.00%
GAIN
Gladstone Investment Corp
13.750
USD
-1.08%
SENS
Senseonics Holdings Inc
0.745
USD
-0.67%
PROK
ProKidney Corp
0.886
USD
-17.96%
ATRO
Astronics Corp
22.690
USD
+0.22%
STOK
Stoke Therapeutics Inc
9.760
USD
+2.63%
RNAC
Cartesian Therapeutics Inc
12.000
USD
+0.84%
MGTX
MeiraGTx Holdings PLC
7.090
USD
+2.75%
EVLV
Evolv Technologies Holdings Inc
4.390
USD
+7.07%
ANGO
AngioDynamics Inc
9.290
USD
-3.03%
FAQ
What is Wellgistics Health Inc (WGRX) stock price today?
The current price of WGRX is 4.34 USD — it has increased 7.96 % in the last trading day.
What is Wellgistics Health Inc (WGRX)'s business?
What is the price predicton of WGRX Stock?
What is Wellgistics Health Inc (WGRX)'s revenue for the last quarter?
What is Wellgistics Health Inc (WGRX)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Wellgistics Health Inc (WGRX)'s fundamentals?
How many employees does Wellgistics Health Inc (WGRX). have?